NCT03611582 - Research Study to Look at How Well Semaglutide is at Lowering Weight When Taken Together With an Intensive Lifestyle Program | Biotech Hunter

Enrollment

611

Participants

Timeline

Start Date

August 1, 2018

Primary Completion Date

March 18, 2020

Study Completion Date

April 28, 2020

Conditions

OverweightObesity

Interventions

DRUG

Semaglutide

Subcutaneous (s.c., under the skin) injections of semaglutide once weekly at escalating doses (0.25 mg/week, 0.5 mg/week, 1.0 mg/week, 1.7 mg/week, 2.4 mg/week). The dose will be escalated to next level every 4 weeks.

DRUG

Placebo (semaglutide)

S.c. injections of placebo once weekly at a similar dose escalation manner as semaglutide (placebo matched to semaglutide 0.25 mg/week, 0.5 mg/week, 1.0 mg/week, 1.7 mg/week, 2.4 mg/week). The dose will be escalated to next level every 4 weeks.

Trial Locations (41)

12203

Novo Nordisk Investigational Site, Albany

13760

Novo Nordisk Investigational Site, Endwell

22206

Novo Nordisk Investigational Site, Arlington

23606

Novo Nordisk Investigational Site, Newport News

27408

Novo Nordisk Investigational Site, Greensboro

27517

Novo Nordisk Investigational Site, Chapel Hill

27609

Novo Nordisk Investigational Site, Raleigh

28401

Novo Nordisk Investigational Site, Wilmington

28601

Novo Nordisk Investigational Site, Hickory

29425

Novo Nordisk Investigational Site, Charleston

29464

Novo Nordisk Investigational Site, Mt. Pleasant

30076

Novo Nordisk Investigational Site, Roswell

32401

Novo Nordisk Investigational Site, Panama City

33324

Novo Nordisk Investigational Site, Plantation

34744

Novo Nordisk Investigational Site, Kissimmee

35294

Novo Nordisk Investigational Site, Birmingham

36106

Novo Nordisk Investigational Site, Montgomery

37912

Novo Nordisk Investigational Site, Knoxville

60077

Novo Nordisk Investigational Site, Skokie

60607

Novo Nordisk Investigational Site, Chicago

75032

Novo Nordisk Investigational Site, Rockwall

75226

Novo Nordisk Investigational Site, Dallas

75230

Novo Nordisk Investigational Site, Dallas

75231

Novo Nordisk Investigational Site, Dallas

78681

Novo Nordisk Investigational Site, Round Rock

78731

Novo Nordisk Investigational Site, Austin

80401

Novo Nordisk Investigational Site, Golden

84790

Novo Nordisk Investigational Site, St. George

85381

Novo Nordisk Investigational Site, Peoria

90057

Novo Nordisk Investigational Site, Los Angeles

92025

Novo Nordisk Investigational Site, Escondido

92648

Novo Nordisk Investigational Site, Huntington Beach

92801

Novo Nordisk Investigational Site, Anaheim

92835

Novo Nordisk Investigational Site, Fullerton

93720

Novo Nordisk Investigational Site, Fresno

94598

Novo Nordisk Investigational Site, Walnut Creek

96814

Novo Nordisk Investigational Site, Honolulu

98502

Novo Nordisk Investigational Site, Olympia

60201-2477

Novo Nordisk Investigational Site, Evanston

19104-3317

Novo Nordisk Investigational Site, Philadelphia

22601-3834

Novo Nordisk Investigational Site, Winchester